Response to therapy and survival in CLL is influenced by genetic markers. preliminary analysis from the LRF CLL4 trial.

被引：10

作者：

Catovsky, D

Richards, S

Matutes, E

Burford, A

Brito-Babapulle, V

Dearden, C

Morris, P

Pettitt, A

机构：

[1] Inst Canc Res, Hematol Oncol Sect, London SW3 6JB, England

[2] Univ Oxford, Clin Trial Serv Unit, Oxford, England

[3] Univ Liverpool, Royal Liverpool Hosp, Dept Haematol, Liverpool L69 3BX, Merseyside, England

来源：

关键词：

D O I：

10.1182/blood.V104.11.13.13

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：8A / 8A

页数：1